SILANI, VINCENZO
SILANI, VINCENZO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Induced Pluripotent Stem Cell (iPSC)-derived Microglia and Organoids for neuronal disease modeling
2025 E. Pellegrini, C. Lattuada, S. Invernizzi, V. Casiraghi, S. Santangelo, V. Silani, A. Ratti, P. Bossolasco
Characterization of human healthy i3 lower motor neurons exposed to CSF from ALS patients stratified by UNC13A and C9ORF72 genotype
2025 V. Casiraghi, E. Pellegrini, A. Brusati, S. Peverelli, S. Invernizzi, S. Santangelo, C. Colombrita, F. Verde, N. Ticozzi, V. Silani, A. Ratti
Impact of APOE and MAPT genetic profile on the cognitive functions among Amyotrophic Lateral Sclerosis Tunisian patients
2025 I. Sghaier, I. Kacem, A. Ratti, K. Takout, Y. Abida, S. Peverelli, N. Ticozzi, A. Gargouri-Berrachid, V. Silani, R. Gouider
Association of Amyotrophic Lateral Sclerosis and Dopa-responsive dystonia in a Tunisian patient
2025 I. Kacem, I. Sghaier, H. Ben Rhouma, A. Ratti, N. Ticozzi, V. Silani, N. Gouider-Khouja, R. Gouider
Bridging the Gap of ALS Missing Heritability: Are Neurogenes Being Overlooked?
2025 A. Manini, A. Brusati, J. Spagliardi, S. Leoni, V. Pensato, S. Peverelli, P.J. Keagle, S. Magri, G. Scacciatella, A. Maranzano, B. Poletti, D. Gentilini, A. Doretti, S. Messina, C. Morelli, F. Verde, C. Gellera, V. Silani, A. Ratti, J.E. Landers, N. Ticozzi
Unraveling the role of NEK1 on primary cilia using mutant iPSC models
2025 S. Invernizzi, V. Casiraghi, V. Casarotto, S. Santangelo, E. Pellegrini, J. Landers, V. Silani, P. Bossolasco, A. Ratti
Clinical usefulness of the Verbal Fluency Index (VFI) in amyotrophic lateral sclerosis
2025 E.N. Aiello, B. Curti, S. Torre, G. De Luca, A. Maranzano, E. Colombo, C. Gendarini, A. Cocuzza, S. Messina, A. Doretti, F. Verde, C. Morelli, V. Silani, N. Ticozzi, B. Poletti
Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study
2025 E. Colombo, A. Doretti, R. Rao, F. Verde, M. Sodano, A. De Gobbi, F.S. di Cola, G. Ceccardi, B. Fiducia, V. Quaresima, C. Tolassi, A. Rizzardi, S. Pierro, V. Thirumoorthi, A. Bettinelli, D. Ungaro, A. Ratti, V. Silani, S. Messina, A. Pilotto, A. Padovani, N. Ticozzi
KIF5Ap.Pro986Leu Risk Variant and Accelerated Progression of Amyotrophic Lateral Sclerosis
2025 A. Manini, R. Vasta, A. Brusati, F. Scheveger, S. Peverelli, A. Maranzano, A. Doretti, F. Gentile, E. Colombo, M. Brunetti, C. Moglia, A. Canosa, U. Manera, M. Grassano, D. Gentilini, S. Messina, F. Verde, C. Morelli, J.E. Landers, B.J. Traynor, A. Chiò, V. Silani, A. Calvo, A. Ratti, N. Ticozzi
Modeling of TDP-43 proteinopathy by chronic oxidative stress identifies rapamycin as beneficial in ALS patient-derived 2D and 3D iPSC models
2025 V. Casiraghi, M.N. Sorce, S. Santangelo, S. Invernizzi, P. Bossolasco, C. Lattuada, C. Battaglia, M. Venturin, V. Silani, C. Colombrita, A. Ratti
Induced Pluripotent Stem Cell (iPSC)-derived Microglia for ALS modeling
2025 E. Pellegrini, C. Lattuada, S. Invernizzi, V. Casiraghi, S. Santangelo, V. Silani, A. Ratti, P. Bossolasco
Oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling and therapeutic implications
2025 A. Iacoangeli, A.A. Dilliott, A. Al Khleifat, P.M. Andersen, N.A. Basak, J. Cooper-Knock, P. Corcia, P. Couratier, M. Decarvalho, V.E. Drory, J.D. Glass, M. Gotkine, Y.M. Lerner, O. Hardiman, J.E. Landers, R.L. Mclaughlin, J.S.M. Pardina, K. Morrison, S. Pinto, M. Povedano, C.E. Shaw, P.J. Shaw, V. Silani, N. Ticozzi, P. Van Damme, L.H. Van Den Berg, P. Vourc'H, M. Weber, J.H. Veldink, R. Dobson, G.A. Rouleau, A. Al-Chalabi, S.M.K. Farhan
Characterization of human healthy i3 lower motor neurons exposed to CSF from ALS patients stratified by UNC13A and C9ORF72 genotype
2025 V. Casiraghi, E. Pellegrini, A. Brusati, S. Peverelli, S. Invernizzi, S. Santangelo, C. Colombrita, F. Verde, N. Ticozzi, V. Silani, A. Ratti
Quantification of serum TDP-43 and neurofilament light chain in patients with amyotrophic lateral sclerosis stratified by UNC13A genotype
2024 V. Casiraghi, I. Milone, A. Brusati, S. Peverelli, A. Doretti, B. Poletti, L. Maderna, C. Morelli, N. Ticozzi, V. Silani, F. Verde, A. Ratti
Distribution of the C9orf72 hexanucleotide repeat expansion in healthy subjects: a multicenter study promoted by the Italian IRCCS network of neuroscience and neurorehabilitation
2024 E. Giardina, P. Mandich, R. Ghidoni, N. Ticozzi, G. Rossi, C. Fenoglio, F.D. Tiziano, F. Esposito, S. Capellari, B. Nacmias, R. Mineri, R. Campopiano, L. Di Pilla, F. Sammarone, S. Zampatti, C. Peconi, F. De Angelis, I. Palmieri, C. Galandra, E. Nicodemo, P. Origone, F. Gotta, C. Ponti, R. Nicsanu, L. Benussi, S. Peverelli, A. Ratti, M. Ricci, G. Di Fede, S. Magri, M. Serpente, S. Lattante, T. Domi, P. Carrera, E. Saltimbanco, S. Bagnoli, A. Ingannato, A. Albanese, F. Tagliavini, R. Lodi, C. Caltagirone, S. Gambardella, E.M. Valente, V. Silani
Investigating the prevalence of MFN2 mutations in amyotrophic lateral sclerosis: insights from an Italian cohort
2024 E. Abati, D. Gagliardi, A. Manini, R. Del Bo, D. Ronchi, M. Meneri, F. Beretta, A. Sarno, F. Rizzo, E. Monfrini, A. Di Fonzo, M.T. Pellecchia, A. Brusati, V. Silani, G.P. Comi, A. Ratti, F. Verde, N. Ticozzi, S. Corti
Disease disclosure in the workplace in people living with rheumatic diseases: an exploratory study
2024 S.M.T. Ostuzzi, E.N. Aiello, F. Ingegnoli, C. Pistarini, B. Poletti, V. Silani, E. Fiabane
Frontotemporal-spectrum disorders and functional independence in non-demented ALS patients
2024 E.N. Aiello, F. Solca, S. Torre, F. Gentile, F. Scheveger, M. Olivero, E. Colombo, A. Maranzano, M. Manzoni, C. Morelli, A. Doretti, F. Verde, V. Silani, N. Ticozzi, B. Poletti
Characterization of human i3 motor neurons exposed to CSF from ALS patients stratified by C9ORF72 and UNC13A genotype
2024 V. Casiraghi, E. Pellegrini, A. Brusati, S. Peverelli, S. Invernizzi, S. Santangelo, C. Colombrita, V. Silani, A. Ratti
Reliable change indices for the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson’s disease patients
2024 E.N. Aiello, F. Solca, S. Torre, B. Curti, G. De Luca, R. Bonetti, F. Scheveger, E. Colombo, A. Maranzano, M. Olivero, C. Morelli, A. Doretti, L. Maderna, F. Verde, R. Ferrucci, S. Barbieri, F. Ruggiero, D. Mellace, A. Marfoli, A. De Sandi, A. Priori, G. Pravettoni, V. Silani, N. Ticozzi, A. Ciammola, B. Poletti